ok.med

Also known as: Psoriasis · Plaque psoriasis · Psoriatic arthritis ·

Psoriasis is a long-term skin condition causing itchy, painful patches of dry, flaky skin. It is not contagious and cannot be cured, but it can be managed. Replying to the Legislative Council in 2020, the Food and Health Bureau set out the treatment options — topical and oral medicines, phototherapy and biologic therapy, prescribed according to severity — and stated that most patients are controlled on the conventional options.

Hong Kong has 127 registered Dermatology & Venereology doctors.

Source: Medical Council of Hong Kong register · read 2026-09-22

ok.med editorial team ·
Compiled by the editorial team from the sources listed below. Not reviewed by an individual doctor.

What is psoriasis, and is it contagious?

Psoriasis — 銀屑病 in the clinical register — is a long-term skin condition producing itchy, painful patches of dry, flaky skin. The NHS states it plainly: psoriasis is not contagious, so it cannot be caught and cannot be passed on.

The two names are the same thing. Hong Kong government documents use 銀屑病 throughout; everyday speech mostly uses 牛皮癬. The difference is register, not diagnosis, neither word is more correct than the other, and either will be understood at a consultation.

That it does not spread is worth stating on its own, because being assumed contagious is part of the actual burden of the disease. Visible red plaques with silvery scale are easily mistaken for a fungal or infectious rash, and people are avoided at pools, gyms, barbers and work because of it. That is a misunderstanding, not a hygiene issue.

The second thing to be clear about: psoriasis cannot currently be cured. The NHS puts it as "it cannot be cured, but there are treatments to help manage your symptoms". No treatment aims at eradication, and any product or course promising a cure is at odds with that consensus.

What does psoriasis look like, and how does it differ from eczema?

The typical presentation is well-demarcated red plaques covered in silvery scale, commonly on the elbows, knees, scalp and lower back, and it can affect the nails. Telling psoriasis from eczema needs examination, not picture-matching.

The NHS notes that symptoms often start either between the ages of 15 and 25, or between 50 and 60. That two-peak pattern explains why psoriasis appears both in young adults and for the first time in middle age — the latter often put down to dry skin or ageing and left.

Nail changes are the part most often missed. Pitting, discolouration, thickening or separation from the nail bed can all be psoriasis, and they look much like a fungal nail. The two are managed quite differently — a separate page here covers the fungal side — and distinguishing them is a doctor’s job.

The difference from eczema is not one feature but the overall morphology, distribution and course, plus whether nails and joints are involved. A separate eczema page sits alongside this one; both are chronic skin conditions travelling the same public dermatology route, and they are nonetheless different diseases treated differently.

What causes psoriasis, and why does it keep flaring?

Psoriasis is a long-term immune-mediated condition, not a consequence of poor washing or diet. The NHS lists nine things that can trigger a flare.

The triggers the NHS lists:

  • Stress
  • Alcohol
  • Smoking
  • Obesity
  • Pregnancy
  • Certain medicines
  • Infections, including strep A and HIV
  • Skin injury
  • Sunlight

That list has a practical use: it turns "what did I do wrong" into something that can be worked through item by item. The nine fall into three groups, and they are not handled the same way.

  • Stress, alcohol, smoking and weight: the group you can act on yourself — and acting on it also lowers the cardiovascular risk the guideline asks to be assessed.
  • Pregnancy and certain medicines: the group to raise with a doctor. Skin worsening after a new medicine is started is a reason to tell the prescriber, not a reason to stop it yourself.
  • Infection and skin injury: the group that cannot be planned for, and the reason a flare sometimes arrives with no warning at all.

That skin injury can trigger new lesions has a direct bearing on day-to-day care: scratching, picking off scale, over-washing and harsh skincare steps can all extend the affected area. Sunlight is one of the few factors that cuts both ways — moderate exposure helps some people, while sunburn is skin injury.

Medical Council of Hong Kong register

127 Dermatology & Venereology doctors in Hong Kong

All 127 ›

The doctors below are listed from the Medical Council of Hong Kong register. This is not a recommendation, and says nothing about outcomes for this condition. Ask the doctor directly.

These are Medical Council registration details, ordered by registration number. ok.med does not rate or recommend doctors, and holds no outcome or satisfaction data.

On ranking, we tell you the truth — today the order follows the Medical Council register. No scores, no sponsored places.

Our algorithm cares about one thing: whether this doctor is most useful to the patient. We publish the rules because trust should never rest on vagueness.

No doctor can pay for a higher ranking.

Is a topical enough, and when does treatment step up?

For most people a topical is enough. Replying to the Legislative Council in 2020, the Food and Health Bureau stated that most patients are controlled on the conventional options — topical or oral medicines or phototherapy, alone or in combination.

"Is a cream enough?" is the first question most people ask, and the answer is yes: topicals genuinely are the first rung, and for most people the only rung. This page recommends no medicine, dose or brand; prescribing is a matter for a doctor and the individual case.

What matters is knowing that the ladder continues. The three rungs the Bureau sets out are topical and oral medicines, phototherapy, and biologic therapy, prescribed according to severity. "I have been using it for ages and it has not helped much" is therefore not the end of the road; it is a reason to be reassessed.

NICE’s guideline adds a point that bears directly on this: targeted immunomodulatory treatments should be initiated and supervised only by consultant dermatologists experienced in diagnosing and treating psoriasis. Stepping up is therefore not a matter of switching tube; it is a change in the level at which the disease is assessed.

How does Hong Kong define severe, and what are the biologic criteria?

The Food and Health Bureau states that the clinical guideline assesses severity three ways: the percentage of total skin affected, PASI, and the Dermatology Life Quality Index. To receive a biologic, the disease must be uncontrolled on conventional treatment, or conventional treatment must be intolerable because of serious adverse effects, with no contraindication present.

The three assessments the clinical guideline uses:

  • The percentage of total skin affected
  • PASI, the Psoriasis Area and Severity Index
  • The Dermatology Life Quality Index, which measures the effect on living

One of those three does not measure skin. The Dermatology Life Quality Index measures the effect on living — sleep, work, social life, mood. Its presence in the Hong Kong criteria means that limited area with severe impact on life is, institutionally, something the gate can see rather than something it necessarily excludes.

The criteria are not a local invention. The Bureau states that the Department of Health and the Hospital Authority drew on the relevant UK guidance to set Hong Kong’s psoriasis biologic treatment and referral guideline in 2014; the Department then revised the clinical guideline for the dermatology biologic service in 2018 following the UK’s 2017 update, and describes the revised clinical requirement as less strict than the original.

So the PASI and the Dermatology Life Quality Index in the NICE guideline are the same two tools named in the Hong Kong criteria — not a coincidence but a lineage. The practical consequence for a reader is that what the UK guideline says about those assessments is a fair guide to how the Hong Kong gate works.

Hong Kong biologic therapy service: patients identified and referred, as at September 2020
StatusPatientsWhat it means
Identified as possibly suitable for biologic therapy90Identified at the Department’s dermatology specialist clinics — the starting point is attending them
Seen at the biologic therapy specialist clinic69A further four were being given an appointment within about four weeks
Referred but no appointment booked at that clinic17A referral still leaves the appointment to be made by the patient
Receiving biologic therapy49This was the actual figure for the whole public system at the time

Can psoriasis affect the joints?

Yes. Psoriatic arthritis is a long-term joint condition that people with psoriasis can develop. NICE recommends offering annual assessment for psoriatic arthritis to people with any type of psoriasis, noting that assessment is especially important within the first 10 years of onset.

The word "annual" matters: it makes joint assessment routine rather than something raised only once the pain is unbearable.

What the NHS lists:

  • Joint pain, swelling and stiffness
  • A whole swollen finger or toe
  • Nail discolouration or pitting
  • Fatigue
  • Symptoms often worse in the morning, easing with movement

The UK guideline also names the tool and the destination: a validated tool such as the Psoriasis Epidemiological Screening Tool (PEST) can be used in both primary and specialist settings, with the caveat that PEST does not detect axial arthritis or inflammatory back pain; and as soon as psoriatic arthritis is suspected the person should be referred to a rheumatologist.

The practical consequence in Hong Kong is that skin and joints may sit with two different specialties. If joint symptoms persist, attending dermatology does not automatically deal with the joint half — and on the UK guideline, that is precisely the point at which a referral should be asked for.

At a glance

The psoriasis treatment ladder in Hong K

The psoriasis treatment ladder in Hong Kong: replying to the Legislative Council in October 2020, the Food and Health Bureau set out topical and oral medicines, phototherapy and biologic therapy, and stated that most patients are controlled on the conventional options. To reach a biologic, the disease must be uncontrolled on conventional treatment or intolerable because of serious adverse effects, with no contraindication. As at September 2020 the Department of Health’s dermatology clinics had identified 90 patients as possibly suitable, of whom 49 were receiving biologic therapy.
Data: Food and Health Bureau reply to LegCo Question 9 (21 October 2020) · Read the original ›

What is the link between psoriasis and cardiovascular disease?

NICE recommends that adults with severe psoriasis of any type be offered a cardiovascular risk assessment at presentation using a validated risk estimation tool, with further assessment every 5 years, or more often if indicated.

This is the part most often skipped because it is not about skin. It is also why psoriasis is treated as a systemic condition rather than a skin complaint: writing cardiovascular risk assessment into the management of a skin disease is itself a judgement. "Severe" in that recommendation means needing phototherapy or systemic treatment, or hospital admission.

The same guideline notes that psoriasis of any type, especially if severe, is a risk factor for venous thromboembolism in adults, and advises explaining that risk and how to minimise it during hospital admission, surgery or periods of immobility.

Separate pages here cover hypertension and diabetes, including Hong Kong’s chronic disease co-care scheme and its long-term follow-up. For someone with psoriasis who also carries those risk factors, the two kinds of follow-up are one matter rather than two.

What helps day to day?

Work from the triggers rather than from washing harder. The modifiable items on the NHS list are stress, alcohol, smoking and weight; skin injury also provokes new lesions, so scratching, picking off scale and harsh skincare are all worth avoiding.

The UK guideline is more specific about lifestyle than is usually assumed: for people with any type of psoriasis, discuss the risk factors for cardiovascular comorbidity and, where appropriate, offer preventive advice, healthy lifestyle information and tailored support for behaviour change — naming weight, diabetes, smoking and alcohol as the directions of travel.

Stopping smoking, drinking less and managing weight therefore do two jobs at once here: they remove flare triggers, and they address the comorbidity risk the guideline asks to be assessed in any case. That is one of the few situations with no trade-off between the two goals.

As for emollients, the NHS lists them among the treatment options rather than as an extra care step. What to use and for how long is a matter for a doctor and the individual case; this page recommends no product.

How does the public system handle psoriasis in Hong Kong?

Dermatology in Hong Kong is provided by the Department of Health and the Hospital Authority separately, and biologic therapy for psoriasis runs on its own referral route. Each item below is cited from the Government’s published replies to the Legislative Council.

  • The question put at the Legislative Council sitting of 21 October 2020 cited over 20,000 psoriasis patients in Hong Kong in 2019, of whom about 5,000 had moderate or severe disease. Note that these figures come from the Member’s question, not from the Bureau’s written reply.LegCo Question 9: Support for psoriasis patients (21 October 2020) · read · (source)
  • The Food and Health Bureau states that treatment for psoriasis comprises topical and oral medicines, phototherapy and the recently introduced biologic therapy; doctors prescribe according to severity, and most patients are controlled on the conventional options.LegCo Question 9: Support for psoriasis patients (21 October 2020) · read · (source)
  • Having referred to the relevant UK guidance, the Department of Health and the Hospital Authority set Hong Kong’s psoriasis biologic treatment and referral guideline in 2014; the Department then revised the clinical guideline for the dermatology biologic service in 2018 following the UK’s 2017 update, describing the revised clinical requirement as less strict than the original.LegCo Question 9: Support for psoriasis patients (21 October 2020) · read · (source)
  • The Chai Wan Social Hygiene Clinic, at Pamela Youde Nethersole Eastern Hospital, has run a biologic therapy specialist clinic led by the Department of Health’s dermatologists since June 2018. Before that, from June 2016 the Department operated a fast direct referral under which its specialists assessed and booked patients into the dermatology biologic clinic at Prince of Wales Hospital; by May 2018 four severe psoriasis patients had been referred under that mechanism.LegCo Question 9: Biologic therapy for psoriasis patients (30 May 2018) · read · (source)
  • Under the criteria in that guideline, a patient whose disease is not controlled by conventional treatment, or who cannot tolerate it because of serious adverse effects, and who has no contraindication, may receive biologic therapy in the public system under the existing mechanism. Severity is assessed three ways: the percentage of total skin affected, PASI, and the Dermatology Life Quality Index.LegCo Question 9: Support for psoriasis patients (21 October 2020) · read · (source)
  • As at September 2020 the Department of Health’s dermatology specialist clinics had identified 90 patients as possibly suitable for biologic therapy; the biologic therapy clinic had seen 69 of them, four were being given an appointment within about four weeks, and 17 referred patients had not booked at that clinic. At that time 49 patients were receiving biologic therapy.LegCo Question 9: Support for psoriasis patients (21 October 2020) · read · (source)
  • The Hospital Authority Drug Formulary carries several biologics for psoriasis, six of which fall within the Samaritan Fund’s subsidy: infliximab, ustekinumab, adalimumab, etanercept, secukinumab and guselkumab. Patients with a clinical need who meet the criteria may apply for drug cost assistance. Which medicine, if any, is a matter for a doctor; this page recommends none.LegCo Question 9: Support for psoriasis patients (21 October 2020) · read · (source)
  • Waits at the Department of Health’s dermatology clinics fall into two classes: severe skin disease new cases are all seen within eight weeks, with a median wait of 2.9 weeks (2023 to 30 September); other stable new cases have a median wait of 90 weeks, with the longest reaching 183 weeks. Psoriasis travels the same route, so whether it is classed severe determines the wait directly.LegCo Question 17: Provision of treatment for eczema patients (8 November 2023) · read · (source)
  • By the Department of Health’s summary of fees, attendance at a dermatology clinic costs $250 for an eligible person and $850 for a non-eligible one, under the schedule effective 1 January 2026. Every new case needs a doctor’s referral letter, and a first attendance requires identity documents and a referral from a registered Hong Kong doctor.Department of Health: summary of fees for public health services — outpatient · read · (source)
  • So that patients in need are not kept from treatment by the charges, the Department of Health operates an established waiver: holders of Comprehensive Social Security Assistance, of a level-zero voucher under the Pilot Scheme on Residential Care Service Voucher for the Elderly, or of a medical fee waiver under the public hospital and clinic waiver mechanism, are exempt from the fees.LegCo Question 9: Support for psoriasis patients (21 October 2020) · read · (source)

When should you seek care straight away?

  • Skin rapidly reddening over a wide area with pus-filled bumps — the NHS lists this as a reason to call 999 or attend A&E.
  • Erythroderma or generalised pustular psoriasis — the UK guideline states these should be referred immediately for same-day specialist assessment and treatment.
  • Recurring joint pain, stiffness and swelling, or a whole swollen finger or toe — seek assessment for psoriatic arthritis; the UK guideline says to refer to a rheumatologist as soon as it is suspected.
  • Any type of psoriasis in a child or young person — the UK guideline says to refer to a specialist at presentation, regardless of extent.
  • Continued worsening despite treatment as directed, or flares becoming more frequent — on the ladder the Food and Health Bureau describes, this is a reason for severity to be reassessed.
  • An adverse reaction to a prescribed medicine — tell the prescribing doctor at once; do not stop or increase it on your own.

Each has its own page and doctor list

By district

Which districts have Dermatology & Venereology doctors?

Frequently asked questions

Are 牛皮癬 and 銀屑病 the same thing?
They are the same disease. Hong Kong government documents use 銀屑病 throughout; everyday speech and search use 牛皮癬. The difference is register, not diagnosis or severity, and it does not change which specialty to attend.
Is psoriasis contagious?
No. The NHS states that psoriasis is not contagious: it cannot be caught and cannot be passed on. Red plaques with silvery scale are easily mistaken for an infectious rash, but that is a misreading of the appearance.
The cream is not working — what now?
That is a reason to have severity reassessed. The Food and Health Bureau sets out three rungs — topical and oral medicines, phototherapy, biologic therapy — prescribed according to the disease. Persistent lack of response should be reviewed by a doctor rather than met by changing or increasing medicine yourself. This page recommends no medicine.
When does the public system use biologics?
Under the Department of Health’s clinical guideline, the disease must be uncontrolled on conventional treatment, or conventional treatment intolerable because of serious adverse effects, with no contraindication. Severity is assessed by percentage of skin affected, PASI, or the Dermatology Life Quality Index. As at September 2020, 49 patients across Hong Kong were receiving biologic therapy.
How long is the public wait?
It depends on the class. At the Department of Health’s dermatology clinics, severe skin disease new cases are all seen within eight weeks, median 2.9 weeks; other stable new cases have a median wait of 90 weeks and a longest wait of 183 weeks. Every new case needs a referral letter.
Is my joint pain related to the psoriasis?
Possibly, and it should be assessed. The UK guideline recommends annual assessment for psoriatic arthritis in anyone with psoriasis, especially in the first 10 years after onset, and referral to a rheumatologist as soon as it is suspected. Persistent joint pain, stiffness or swelling, or a whole swollen finger or toe, are all reasons to seek care.
Can psoriasis be cured?
No. The NHS states that psoriasis cannot be cured but that treatments can help manage the symptoms. The goal is control, not eradication, and any product or course promising a cure is at odds with that.
Discoloured nails — fungus or psoriasis?
Either. Pitting, discolouration, thickening or separation from the nail bed can be psoriasis, and it looks much like a fungal nail, yet the two are managed quite differently. Distinguishing them needs examination; comparing against pictures is not reliable. A separate page here covers the fungal side.

Sources

  1. LegCo Question 9, Support for psoriasis patients — the Secretary for Food and Health’s written reply, carrying the three rungs of treatment, the origin of Hong Kong’s biologic treatment and referral guideline, the three severity assessments, the Chai Wan clinic, the patient counts as at September 2020, the six Samaritan Fund biologics and the fee waiver. Government press release (Food and Health Bureau) ()
  2. LegCo Question 9, Provision of biologic therapy for psoriasis patients — the fast direct referral mechanism from June 2016, the biologic clinic at Prince of Wales Hospital, and the preparation of the clinic at Pamela Youde Nethersole Eastern Hospital. Government press release (Food and Health Bureau) ()
  3. LegCo Question 17, Provision of treatment for eczema patients — the median and longest waits at the Department of Health’s dermatology clinics for severe skin disease and for other stable new cases. Psoriasis travels the same route. Government press release ()
  4. Department of Health: summary of fees for public health services (outpatient) — dermatology clinic charges and the effective date of the schedule. Department of Health ()
  5. NHS: psoriasis — the definition, that it is not contagious and cannot be cured, the two peaks of onset, the list of triggers, the categories of treatment, and when to seek urgent care. National Health Service (UK) ()
  6. NHS: psoriatic arthritis — the symptoms, its relationship to psoriasis, and when to see a doctor. National Health Service (UK) ()
  7. NICE CG153, Psoriasis: assessment and management — the tools for severity and impact (the Dermatology Life Quality Index), annual assessment for psoriatic arthritis and the PEST tool, referral to rheumatology on suspicion, cardiovascular risk assessment in severe psoriasis, venous thromboembolism risk, and that targeted immunomodulatory treatments are initiated and supervised only by consultant dermatologists. National Institute for Health and Care Excellence (NICE) ()

This page is compiled from the Hong Kong official sources listed above. It is general information only — not a diagnosis, a treatment recommendation or medical advice, and no substitute for seeing a doctor. If you are unsure or your condition changes, consult a registered doctor.